Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anxiety Over Prospects For Legislative 510(k) Reform Appears To Be Growing

This article was originally published in The Gray Sheet

Executive Summary

FDA and industry are concerned Congress will revise the 510(k) process and defended the program and warned against statutory reforms during a panel discussion at the Food and Drug Law Institute annual meeting in Washington, D.C
Advertisement

Related Content

510(k) Reform Debate Resurfaces As GAO Completes Mandated Report
510(k) Reform Debate Resurfaces As GAO Completes Mandated Report
FDA Device Chief Issues Caution On 510(k)s: Data Requests Could Get Steeper
Scrutinizing 510(k)s: Critical Voices Get Heard In Congress
Scrutinizing 510(k)s: Critical Voices Get Heard In Congress
Advertisement
UsernamePublicRestriction

Register

MT025933

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel